SCHEDULE: 683 Capital Management Discloses Fractyl Health Stake

683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman have reported beneficial ownership of 7,679,615 shares of Fractyl Health, Inc. common stock, representing 4.81% of the outstanding shares.

Summary

• 683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman (collectively, the 'Reporting Persons') have filed a Schedule 13G, indicating their beneficial ownership of Fractyl Health, Inc. common stock.
• As of March 31, 2026, 683 Capital Partners, LP held 6,727,235 shares of common stock and warrants to purchase an additional 952,380 shares.
• 683 Capital Management, LLC, as the investment manager for 683 Capital Partners, LP, and Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, are deemed to beneficially own these shares and warrants.
• As of May 15, 2026, the total beneficial ownership amounts to 7,679,615 shares of common stock, which represents approximately 4.81% of the outstanding shares.
• This percentage is calculated based on 158,648,963 shares of common stock outstanding (as per the Issuer's Form 10-K filed on March 24, 2026) plus the 952,380 shares issuable upon exercise of currently exercisable warrants held by the Reporting Persons.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates a significant investment by an institutional entity, but it does not provide operational or financial updates from the company itself.

Positives

• The Reporting Persons have acquired a significant stake (4.81%) in Fractyl Health, Inc., indicating confidence in the company's prospects.
• The ownership includes both directly held shares and exercisable warrants, suggesting a potential for increased future ownership and a belief in the company's valuation.

Negatives

• The filing does not contain any negative financial results or operational challenges for Fractyl Health, Inc. itself, as it is a Schedule 13G disclosure of ownership.

Risks

• The primary risk for the Reporting Persons is the potential fluctuation in the market price of Fractyl Health, Inc. common stock, which could impact the value of their investment.
• There is a risk associated with the exercise of warrants, as the company's performance and stock price will determine the profitability of this option.

Future Outlook

The filing does not contain forward-looking statements or guidance from Fractyl Health, Inc. It is a disclosure of beneficial ownership by 683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes by institutional investors or hedge funds. A stake of 4.81% in Fractyl Health, Inc. by 683 Capital Management suggests a significant, but not controlling, interest, often preceding potential activist involvement or simply reflecting a strategic investment thesis.

Stakeholder Impact

• Shareholders: The increased institutional interest may be viewed positively, potentially leading to greater scrutiny and engagement with management, which could influence stock performance.
• Management of Fractyl Health, Inc.: The significant stake held by 683 Capital Management may lead to increased engagement or dialogue with the company's board and management.
• Potential Investors: The filing provides transparency on a significant ownership block, which can inform investment decisions by other market participants.

Next Steps

• The Reporting Persons will continue to monitor their investment in Fractyl Health, Inc.
• The company's future performance will dictate the strategic decisions of the Reporting Persons regarding their stake.

Key Dates

Keywords

Fractyl Health, Schedule 13G, 683 Capital Management, 683 Capital Partners, Ari Zweiman, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Investment Management